The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and purpose: Increases in intracellular cyclic AMP (cAMP) augment the release/secretion of glucagon‐like peptide‐1 (GLP‐1). As cAMP is hydrolysed by cAMP phosphodiesterases (PDEs), we determined the role of PDEs and particularly PDE4 in regulating GLP‐1 release. Experimental approach: GLP‐1 release, PDE expression and activity were investigated using rats and GLUTag cells, a GLP‐1‐releasing cell line. The effects of rolipram, a selective PDE4 inhibitor both in vivo and in vitro and stably overexpressed catalytically inactive PDE4D5 (D556A‐PDE4D5) mutant in vitro on GLP‐1 release were investigated. Key results: Rolipram (1.5 mg·kg−1 i.v.) increased plasma GLP‐1 concentrations approximately twofold above controls in anaesthetized rats and enhanced glucose‐induced GLP‐1 release in GLUTag cells (EC 50∼1.2 nmol·L−1). PDE4D mRNA transcript and protein were detected in GLUTag cells using RT‐PCR with gene‐specific primers and Western blotting with a specific PDE4D antibody respectively. Moreover, significant PDE activity was inhibited by rolipram in GLUTag cells. A GLUTag cell clone (C1) stably overexpressing the D556A‐PDE4D5 mutant, exhibited elevated intracellular cAMP levels and increased basal and glucose‐induced GLP‐1 release compared with vector‐transfected control cells. A role for intracellular cAMP/PKA in enhancing GLP‐1 release in response to overexpression of D556A‐PDE4D5 mutant was demonstrated by the finding that the PKA inhibitor H89 reduced both basal and glucose‐induced GLP‐1 release by 37% and 39%, respectively, from C1 GLUTag cells. Conclusions and implications: PDE4D may play an important role in regulating intracellular cAMP linked to the regulation of GLP‐1 release. British Journal of Pharmacology (2009) 157, 633–644; doi:10.1111/j.1476‐5381.2009.00194.x; published online 9 April 2009
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402 · cited 2×
“GLP-1 also suppresses gastric motility (Nauck et al., 1997), promotes satiety (Flint et al., 1998) and may possess insulinomimetic actions on glucose disposal (Egan et al., 2002).”
BackgroundGlucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 2×
“L cells, characterized by a high yellow fluorescence, were sorted using a MoFlo Beckman Coulter Cytomation sorter, at numbers of up to 30 000 into 1 mL RNAlater (Reimann et al., 2008).”
MethodSelf-citation
Cited by
Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
Baillie, G. S., Tejeda, G. S., & Kelly, M. P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0033-4 · Cited by 339
Self-citationHatzelmann, A., Morcillo, E. J., Lungarella, G., Adnot, S., Sanjar, S., Beume, R., Schudt, C., & Tenor, H. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.03.011 · Cited by 320
Rabe, K. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01218.x · Cited by 273
Resveratrol as a calorie restriction mimetic: therapeutic implications
Chung, J. H., Manganiello, V., & Dyck, J. R. B. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.07.004 · Cited by 192
Metabolic effects of resveratrol: Addressing the controversies
Bitterman, J. L., & Chung, J. H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1808-8 · Cited by 109
“Secretion of GLP-1 is inhibited by PDE4D [192], and both resveratrol [6] [193] and the PDE4 inhibitor rolipram [6] [192] increase GLP-1 production (Fig.”
Metadata
- Authors
- Ong, W., Gribble, F., Reimann, F., Lynch, M., Houslay, M., Baillie, G., Furman, B., & Pyne, N.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2009-06
- Volume
- 157
- Issue
- 4
- Pages
- 633-644
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1550156414
- Cited by
- 66
- References
- 2
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00194.x
- The paper
- Ong, W., Gribble, F., Reimann, F., Lynch, M., Houslay, M., Baillie, G., Furman, B., & Pyne, N. (2009). The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00194.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.